Posted Nov. 8, 2012 at 10:16 a.m.

Premium Lock RTP firm suspends trial for $235M influenza treatment

Published: 2012-11-08 10:16:00
Updated: 2012-11-08 10:16:00

GSK testing pandemic vaccine GSK testing pandemic vaccine Image 1 of 2 · Next Image…

BioCryst Pharmaceuticals suspends a Phase 3 trial of an intravenously administered influenza treatment for which it has received more than $200 million in federal funding....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll